Squalamine lactate ophthalmic solution 0.2%

squalamine lactate ophthalmic solution · Ohr Pharmaceutical Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Squalamine lactate ophthalmic solution 0.2%, covering 2017-04-27 to 2017-04-27. Get the full timeline:

Most recent: Clinical Trial Update: Effect of Squalamine Lactate Ophthalmic Solution, 0.2% in Subjects With Neovascular Age-Related Macular Degeneration [Phase 2]

See pricing